By Rosie Waterhouse (UK Times)
Mercury in vaccines for babies and infants could be the cause of a steep rise in cases of autism in children around the world, according to a growing number of scientists.
The increase in reports of autism in Britain, America and some other countries coincides with a growth in the number of inoculations given to young children, say the researchers.
Many of the vaccines contain a preservative called thiomersal, which is 49.6% mercury - a substance known to have neurotoxic effects, especially in infants whose brains are still developing.
Symptoms are similar to those displayed by autistic children.
Autism is a spectrum of disorders that range in severity from bizarre, violent behavior to an inability to communicate or interact socially, along with repetitive patterns of behavior.
Estimates of the prevalence of the syndrome in Britain range from 10 cases per 10,000 of the population with "classic" autism, to 9.1 cases per 1,000 showing some signs of autistic behavior.
The National Autistic Society estimates that there are about 500,000 people with autism in Britain, 120,000 of them children. According to one recent study, there has been a tenfold increase among children between 1984 and 1994.
The new possible explanation of the rise has emerged after a two-month review of all the available information by The Sunday Times. Several groups of academics and researchers in America and Sweden are investigating similar theories that a combination of factors is to blame.
They include a genetic predisposition, the cumulative effects of mercury in vaccines lowering the immune system, with the controversial measles, mumps and rubella (MMR) triple vaccine being a possible trigger.
The US Institute of Medicine is so concerned that officials have organized a two-day meeting in July to discuss the "hypothesis" that thiomersal and mercury in vaccines are linked to autism.
Boyd Haley, chemistry professor at the University of Kentucky, has been asked to submit a paper. "Thiomersal is extremely toxic. The preliminary data is convincing and does indicate that vaccines are the most likely suspect for causing autism," he said.
In general, the researchers argue, the cumulative effects of mercury impair brain development and damage the child's immune system and gastrointestinal tract, resulting in hypersensitivity to toxic environmental substances.
This build-up could lead to autism or a form of mercury poisoning - whose symptoms are similar. In addition, researchers believe, the MMR triple vaccine, usually given at 18 months to two years, could trigger autism because the damaged immune system cannot cope with three live viruses at once.
Only some children exposed to mercury will develop symptoms. Researchers believe this indicates that there may be a genetic predisposition. This theory was reinforced by a study published this month that showed that in 99% of autistic children a family of proteins essential for disposing of mercury and other heavy metals is missing or "disabled".
The proteins, called metallothionein (MT), are the main way in which the body counters heavy metal. The study, by the Chicago-based Pfeiffer Center, a health research institute, found that of 503 autistic patients 499 showed an MT "dysfunction".
The number of vaccinations given to babies and children in Britain and America has increased significantly.
In the United States the number given before the age of two has risen from 8 in 1980 to 22 now.
In Britain in 1970, most children received diphtheria, tetanus, polio, whooping cough and BCG for tuberculosis; about half were also immunized against measles. In 1972 rubella was added; MMR in 1988, Hib (Haemophilus Influenza type b), against a form of meningitis in 1992, MMR as a second dose in 1996, and meningitis C in 1999.
The MMR first dose is given between 12 and 15 months, with diphtheria and tetanus and the second dose of MMR at three to five years.
MMR does not contain thiomersal, though other child vaccines do. Thiomersal was introduced in the 1930s as a preservative and went into common use without review by America's Food and Drug Administration (FDA) because it was assumed to be safe.
In America, researchers found some infants who are being vaccinated using multidose vials with thiomersal can receive 62.5 micrograms of mercury per visit.
This is 100 times more than the intake considered safe for the average six-month-old by the US Environmental Protection Agency.
In June 1999 the FDA discovered that: "Infants who receive thiomersal-containing vaccine at several visits may have been exposed to more mercury than recommended by Federal guidelines." The following month the European Agency for the Evaluation of Medicinal Products (EMEA) issued a statement saying: "Cumulative exposure to ethylmercury [found in thiomersal] . . . could lead to a potential cause for concern."
In May last year, a scientist from the US Centers for Disease Control and Prevention (CDC) gave a presentation, based on a study of the Vaccine Safety Datalink Project - a database of 400,000 children - with evidence of harm. Dr Thomas Verstraeten of the CDC found the screening analysis suggests "statistically significant associations" between certain neurologic developmental disorders - such as attention deficit disorder, and speech and language disorders - and exposure to mercury from thiomersal-containing vaccines before the age of six months.
As a result, the EMEA issued another statement last June, saying: "For vaccination in infants and toddlers, as a precautionary measure it would be prudent to promote the general use of vaccines without thiomersal. Moreover, the use of thiomersal-free vaccines should be recommended for newborns."
Neither of these EMEA statements received national newspaper publicity in Britain, and at least 10 thiomersal-containing vaccines for children are still in use as drug manufacturers are permitted to finish stocks.
Jane Maroney El-Dahr, an immunologist at Tulane University medical center in New Orleans, said: "It is important for me to emphasize that the message is not to not vaccinate children, but to make sure that vaccines are thiomersal-free."
The health department said: "Thiomersal has played an important role as a preservative in vaccines.
Because thiomersal contains mercury, both European and American regulators have recently recommended that vaccine manufacturers phase out its use wherever possible as a precaution. They have not recommended the withdrawal of any vaccines.
Imagine that, giving a newborn baby a substance that is highly toxic to the central nervous system.
I have seen hundreds and hundreds of autistic children and have reached the conclusion that many, certainly not all, had the root cause of their illness the hepatitis B vaccine they were given on their first day of breathing air.
The central nervous system of a newborn infant is particularly susceptible to toxic influences. This is one of the reasons why the hepatitis B vaccine is such a problem. If it were given later in life, like many other countries do, it would not be as much of a problem.
This is especially tragic as there is virtually no legitimate indication to give this vaccine at birth. The only infants that may benefit are those born to women infected with hepatitis B.